The Venture Codex Logo

The Venture Codex

Clarium

325 5th Avenue Apartment 39C, New York, 10016, United States

Overview

Clarium Capital is a hedge fund that specializes in early stage ventures. It offers its services to pooled investment vehicles. It also caters to individuals, pension and profit sharing plans, trusts, estates, charitable organizations, funds of funds, corporations, partnerships, and business entities. It manages separate client focused equity and fixed income portfolios. The firm invests in the public equity, fixed income, and hedging markets across the globe. Clarium Capital is a U.S.-based company that was founded by Peter Thiel and Bill Calayag.

Total investments
2
Lead investments
0
Investments · 12mo
0
Active investors
1

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Clarium

    Participated · Equity · Aug 2024

    Clarium builds Astra OS, an AI-powered healthcare supply chain resiliency platform that collects, unifies, and automates crowdsourced data from providers, suppliers, and vendors. The platform predicts supply chain disruptions using real-time weather, geopolitical, and current events data and delivers tailored recommendations for substitutions and disruption resolution. Astra OS spans workflow operations, inventory and stock management, and disruption and substitution optimization, and was developed in collaboration with major health systems. Hospitals adopting Astra OS have seen over $10 million in average cost savings, 50% faster disruption resolution, and 88% substitute approvals. Clarium plans to accelerate Astra OS development with additional apps and solutions, expand its team, and grow relationships with new health system partners. The company has expanded leadership and collaborators since its 2024 seed round and has raised $43 million to date. Clarium builds Astra OS, an AI-powered workflow platform and data ecosystem that unifies real-time supply chain data and delivers workflow applications for hospitals. The platform includes modules such as Disruption Monitor, Substitute Manager, and Card Optimizer to automate inventory management and approvals. Since integrating Astra OS, partners have identified an average of $10M+ in cost savings and productivity gains, including a 50% decrease in disruption resolution time, a 63% decrease in substitute approval time, and a 3.7x growth in clinically validated substitutes approved. Yale New Haven Health reports over 300 users across seven departments actively using the platform. The company was founded in 2020 and is headquartered in New York City. Clarium plans to expand integrations, hire across data science, engineering, sales, product, and customer success, and continue investing in generative AI and large language model technologies to augment its offerings.

  • Cavendish Kinetics

    Participated · Equity · May 2006

    Cavendish Kinetics develops high-performance RF MEMS radio components, including its SmarTune tuners with a MIPI RFFE interface. Its first-generation RF MEMS tuners have fully ramped and been shipping in volume since 2014, and the company cites MEMS cycle life beyond 100 billion cycles. The firm is introducing a new generation that adds virtually loss-less RF MEMS switches and increases tuning range and RF voltage handling. Those components target radio front-end applications such as antenna, filter and power amplifier tuning and ultra-low loss switching of the RF signal path. Samples of the new generation were scheduled for availability in Q1 2016, with volume production planned for the second half of 2016. Cavendish is headquartered in San Jose, CA, and maintains offices in Dallas, China, Korea, and the Netherlands. Cavendish Kinetics designs RF MEMS tuning solutions (SmarTuners) for mobile and wearable devices to improve radio performance, data throughput and battery life. Its SmarTuners have been qualified beyond 50 billion cycles and have been shipping in volume since 2014. The company announced its first commercial product launch earlier this year and is securing customer design-wins, including the nubia Z7 LTE smartphone which uses Cavendish’s tuner to meet China Mobile’s 2GHz LTE requirements. Cavendish says its solutions address spectrum and battery-efficiency challenges in smartphones and wireless networks. The company operates offices in San Jose, CA as well as Korea, Taiwan, China and The Netherlands. Recent funding will support scaling customer engagements and product adoption. Cavendish Kinetics designs and manufactures tunable RF components based on its proprietary NanoMech™ process technology. Its initial products target antenna tuners and impedance-matching devices for mobile devices, with sampling expected early in 2012. The company partners with major semiconductor, module, and handset makers to create tunable RF front ends that help meet size, performance, and cost challenges across global mobile networks. Cavendish said it will use the financing proceeds to produce RF tuning products based on NanoMech. The company has offices in The Netherlands and San Jose, California. Management named in the release includes CEO Dennis Yost and chairman Luiz Arzubi, and the board was expanded to include RF industry veterans Paul Dal Santo and Moiz Beguwala. Cavendish Kinetics develops Nanomech micro-mechanical memory elements and integrates them into standard CMOS to provide embedded non-volatile memory. The company is shifting development emphasis to embedded non-volatile re-programmable Nanomech-based memory and states its embedded flash technology is positioned to meet demands for ultra-low power, robust CMOS-compatible embedded NVM. Target application markets include automotive, microcontroller, and analog/mixed-signal applications. Cavendish aims to expand its market presence among IDMs, fabless semiconductor companies and CMOS foundries. The company is a spin-off of Cambridge University and was founded by Professor Charles G. Smith. The new funding will be used to continue development of Nanomech technology and expand market presence.

Team